MarketCap
Facebook
X
TelegramQuartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Quotient Limited ROCE 2011-2026 | QTNT
ROCE Jährlich Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 232.42 | -41.32 | -51.83 | -72.31 | -92.29 | -49.89 | -112.79 | -52.59 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 232.42 | -112.79 | -30.07 |
ROCE Vierteljährlich Quotient Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 128.08 | 140.73 | 182.0 | 189.78 | 251.55 | -735.45 | -1109.01 | -1222.57 | -1219.0 | -380.69 | -221.13 | -142.99 | -121.39 | -74.76 | -28.13 | 75.53 | -458.81 | -829.03 | -641.58 | -715.25 | -273.89 | 614.87 | 299.29 | 114.39 | 65.47 | -424.82 | -594.65 | -143.44 | -51.11 | 90.14 | 263.81 | -163.13 | -163.13 | -255.46 | -53.98 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 614.87 | -1222.57 | -217.36 |
ROCE anderer Aktien in der Diagnostik & Forschung
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M |  USA |
 |
Agilent Technologies
A
|
25.0 | $ 119.77 | -0.5 % | $ 36.4 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 20.56 | 3.37 % | $ 221 M |  China |
 |
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M |  Israel |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 17.57 | -0.34 % | $ 936 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 1.42 | 2.9 % | $ 1.89 M | USA |
 |
Castle Biosciences
CSTL
|
1.9 | $ 24.62 | 1.03 % | $ 684 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 180.56 | 0.7 % | $ 8.95 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
Danaher Corporation
DHR
|
8.93 | $ 198.14 | -0.2 % | $ 141 B | USA |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 2.2 | - | $ 9.73 M | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-35.1 | $ 132.26 | 1.49 % | $ 21 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
6.33 | $ 29.09 | - | $ 20 B |  Niderland |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 16.17 | 0.94 % | $ 489 M | USA |
 |
Guardant Health
GH
|
440.3 | $ 84.86 | -1.78 % | $ 10.6 B | USA |
 |
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | Niderland |
 |
Anixa Biosciences
ANIX
|
-77.18 | $ 2.93 | 1.74 % | $ 95.1 K | USA |
 |
Biomerica
BMRA
|
-125.14 | $ 2.11 | 0.48 % | $ 4.85 M | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 518.54 | -0.28 % | $ 15 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 116.5 | 3.04 % | $ 9.61 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 266.73 | -0.8 % | $ 22.2 B | USA |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Celcuity
CELC
|
-171.24 | $ 123.47 | 2.17 % | $ 5.77 B | USA |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 5.19 | 5.7 % | $ 481 M | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 83.94 | 1.45 % | $ 5.67 B | USA |
 |
NeoGenomics
NEO
|
-9.11 | $ 8.68 | 3.95 % | $ 1.11 B | USA |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 9.42 | -1.98 % | $ 2.04 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 191.42 | -1.41 % | $ 21.2 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-185.74 | $ 5.14 | 3.63 % | $ 4.05 M | USA |
 |
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | USA |
 |
National Research Corporation
NRC
|
161.47 | $ 17.84 | 4.69 % | $ 399 M | USA |
 |
Natera
NTRA
|
-76.66 | $ 207.19 | -3.47 % | $ 20.4 B | USA |
 |
OpGen
OPGN
|
4.4 | - | -16.95 % | $ 1.54 M | USA |
 |
Organovo Holdings
ONVO
|
-120.24 | - | -2.3 % | $ 19.4 M | USA |
 |
Psychemedics Corporation
PMD
|
-43.78 | - | -1.84 % | $ 15.3 M | USA |